Literature DB >> 15007161

Special considerations in treating the elderly patient with epilepsy.

R Eugene Ramsay1, A James Rowan, Flavia M Pryor.   

Abstract

Epilepsy in elderly patients, compared with the younger adult population, differs in etiology, clinical presentation, and prognosis. Challenges in the pharmacologic treatment of epilepsy in the elderly include the following: the physiologic changes associated with aging; adverse events to which the elderly are especially vulnerable; the increased risk for these patients, who are often taking multiple medications; and toxicity from drug-drug interactions. This article presents data on efficacy and safety from clinical trials of newer antiepileptic drugs (AEDs) in elderly patients compared with older AEDs. We discuss the implications of the findings using newer-generation AEDs in the Veterans Affairs Cooperative Study (VACS) #428 in order to educate physicians involved in choosing appropriate AEDs for older patients. In the elderly patient population, an optimal treatment outcome of seizure control with minimal or no adverse events is dependent on the well-informed choice of an AED by a physician.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15007161     DOI: 10.1212/wnl.62.5_suppl_2.s24

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  49 in total

Review 1.  Ethical Considerations of Patient-Funded Research for Multiple Sclerosis Therapeutics.

Authors:  Lilyana Amezcua; Flavia Nelson
Journal:  Neurotherapeutics       Date:  2017-10       Impact factor: 7.620

2.  Seizures and strokes for certain folks.

Authors:  Robert T Wechsler
Journal:  Epilepsy Curr       Date:  2012-05       Impact factor: 7.500

3.  How important is Alzheimer's disease as a risk factor for unprovoked seizures and epilepsy in the elderly?

Authors:  Bassel W Abou-Khalil
Journal:  Epilepsy Curr       Date:  2010-03       Impact factor: 7.500

4.  Late-onset epilepsy and 25-year cognitive change: The Atherosclerosis Risk in Communities (ARIC) study.

Authors:  Emily L Johnson; Gregory L Krauss; Keenan A Walker; Jason Brandt; Anna Kucharska-Newton; Thomas H Mosley; Sevil Yasar; Rebecca F Gottesman
Journal:  Epilepsia       Date:  2020-07-24       Impact factor: 5.864

Review 5.  Prescribing antiepileptics for the elderly: differences between guideline recommendations and clinical practice.

Authors:  Mary Jo V Pugh; Perry J Foreman; Dan R Berlowitz
Journal:  Drugs Aging       Date:  2006       Impact factor: 3.923

Review 6.  Epilepsy in the elderly.

Authors:  Konrad J Werhahn
Journal:  Dtsch Arztebl Int       Date:  2009-02-27       Impact factor: 5.594

7.  Association Between Midlife Risk Factors and Late-Onset Epilepsy: Results From the Atherosclerosis Risk in Communities Study.

Authors:  Emily L Johnson; Gregory L Krauss; Alexandra K Lee; Andrea L C Schneider; Jennifer L Dearborn; Anna M Kucharska-Newton; Juebin Huang; Alvaro Alonso; Rebecca F Gottesman
Journal:  JAMA Neurol       Date:  2018-11-01       Impact factor: 18.302

Review 8.  Clinical pharmacokinetics of new-generation antiepileptic drugs at the extremes of age.

Authors:  Emilio Perucca
Journal:  Clin Pharmacokinet       Date:  2006       Impact factor: 6.447

Review 9.  Treatment of Epilepsy in the Elderly.

Authors:  Paul V Motika; David C Spencer
Journal:  Curr Neurol Neurosci Rep       Date:  2016-11       Impact factor: 5.081

10.  Seizures in the elderly: impact on mental status, mood, and sleep.

Authors:  Sheryl R Haut; Mindy Katz; Jonathan Masur; Richard B Lipton
Journal:  Epilepsy Behav       Date:  2009-02-02       Impact factor: 2.937

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.